Immunome's market cap is currently $1.37B. The company's EPS TTM is $-0.5; its P/E ratio is ―; Immunome is scheduled to report earnings on August 6, 2025, and the estimated EPS forecast is $-0.57. See an overview of income statement, balance sheet, and cash flow financials.
